Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Prostate cancer patients with hereditary BRCA mutations respond less well to conventional treatment

Prostate cancer patients carrying inherited mutations in the BRCA genes respond less well to conventional treatment, including surgery and/or radiotherapy - and they also have a lower survival rate than those who are non-carriers of these genetic mutations. Data from the study, which has been published in the journal European Urology, points to the need for new clinical trials aimed at targeting these mutations in order to tailor treatment for these patients.

17 Nov 2014

New anti-cancer drug may protect normal cells against radiation

Although radiation treatments have become much more refined in recent years, it remains a challenge to both sufficiently dose the tumor while sparing the surrounding tissue.

14 Nov 2014

Researchers develop genetic test to predict prostate cancer recurrence

Prostate cancer researchers have developed a genetic test to identify which men are at highest risk for their prostate cancer to come back after localized treatment with surgery or radiotherapy.

13 Nov 2014

New DNA-based test could better predict treatment outcomes for prostate cancer patients

Researchers at The Ontario Institute for Cancer Research and University Health Network, have identified a new DNA-based test that could be used to better predict how prostate cancer patients will respond to treatment and to prevent relapse.

13 Nov 2014

CMS to cover low-dose CT screening for lung cancer

The Centers for Medicare and Medicaid Services today recognized the importance of lung cancer screening, announcing today that it will cover low-dose computed tomography (CT) screening, or "CAT" scans , for high-risk current and former smokers. The decision validates Mount Sinai's longstanding commitment to providing access to this essential screening tool.

12 Nov 2014

Breakthrough study shows novel molecular imaging drug to detect early prostate cancer

A novel study demonstrates the potential of a novel molecular imaging drug to detect and visualize early prostate cancer in soft tissue, lymph nodes and bone. The research, published in the November issue of the Journal of Nuclear Medicine, compares the biodistribution and tumor uptake kinetics of two Tc-99m labeled ligands, MIP-1404 and MIP-1405, used with SPECT and planar imaging.

11 Nov 2014

New treatment could halt growth of tumours in prostate cancer patients

Scientists believe a new treatment, shown to be effective in mice, could halt the growth of tumours in patients with prostate cancer.

11 Nov 2014

Inovio Pharmaceuticals reports Q3 2014 financial results, provides corporate update

Inovio Pharmaceuticals, Inc. today reported financial results for the quarter ended September 30, 2014.

10 Nov 2014

Researchers obtain detailed picture of how Gas5 RNA interacts with steroid hormone receptors

It arises from what scientists previously described as "junk DNA" or "the dark matter of the genome," but this gene is definitely not junk.

7 Nov 2014

Integrative medicine therapies can decrease pain, anxiety for hospitalized cancer patients

Pain is a common symptom of cancer and side effect of cancer treatment, and treating cancer-related pain is often a challenge for health care providers.

7 Nov 2014

Olaparib shows promise for advanced cancers associated with BRCA1 and BRCA2 mutations

Olaparib, an experimental twice-daily oral cancer drug, produces an overall tumor response rate of 26 percent in several advanced cancers associated with BRCA1 and BRCA2 mutations, according to new research co-led by the Abramson Cancer Center of the University of Pennsylvania.

7 Nov 2014

Researchers develop diagnostic tool to examine traveling cancer cells, improve health outcomes

For most cancer patients, primary tumours are often not the most deadly. Instead, it is the metastatic tumours - tumours that spread from their original location to other parts of the body - that are the cause of most cancer deaths.

6 Nov 2014

AZD3965 drug inhibits growth of tumours in the lab

Manchester scientists have shown that a new drug inhibits the growth of tumours in the lab and that its effectiveness is improved by combining it with radiotherapy - suggesting a new approach that could be used in the clinic.

6 Nov 2014

ProstaCaid dietary supplement supports prostate health

A recent presentation at an international cancer research conference in Greece reviewed the body of data on ProstaCaid, a dietary supplement compound for prostate health. A number of published studies demonstrate the formula's effects in supporting prostate health against specific prostate cancer cell lines and prostate urinary symptoms.

5 Nov 2014

UT Arlington professor uses tissue-engineered artificial lymph nodes to draw prostate cancer cells

A UT Arlington bioengineering professor is using tissue-engineered artificial lymph nodes to attract prostate cancer cells to better target and eradicate the disease.

5 Nov 2014

New device facilitates diagnosis of prostate cancer

Distinguishing between benign and malignant prostate tissue is difficult. A new device facilitates the diagnosis for doctors: Through a visual analysis, they can reliably determine if they are dealing with carcinoma within a minute-and-a-half. Fraunhofer researchers will be presenting the prototype at the COMPAMED trade fair in Düsseldorf from November 12th to 14th.

5 Nov 2014

Bluebeards Original joins with Lung Cancer Alliance to raise awareness about lung cancer

Bluebeards Original is pleased to announce that it has joined with the Lung Cancer Alliance in the month of November to help raise awareness about lung cancer and lung cancer screening. Throughout the month of November, Bluebeards Original will donate 5% of every purchase made on bluebeardsoriginal.com, while promoting lung cancer awareness on its site and through social media.

5 Nov 2014

Study suggests possible link between body fat and risk of immunotherapy toxicity

Immunotherapy that can be effective against tumors in young, thin mice can be lethal to obese ones, a new study by UC Davis researchers has found.

4 Nov 2014

UC Davis researchers link increased body fat and lethal drug reactions in mice

Immunotherapy that can be effective against tumors in young, thin mice can be lethal to obese ones, a new study by UC Davis researchers has found. The findings, published online today in The Journal of Experimental Medicine, suggest a possible link between body fat and the risk of toxicity from some types of immunotherapy.

3 Nov 2014

Findings could lead to single blood test for early detection of many types of cancer

Scientists have identified more than 800 markers in the blood of cancer patients that could help lead to a single blood test for early detection of many types of cancer in future, according to research presented at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool today (Sunday).

3 Nov 2014

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Prostate cancer patients with hereditary BRCA mutations respond less well to conventional treatment

New anti-cancer drug may protect normal cells against radiation

Researchers develop genetic test to predict prostate cancer recurrence

New DNA-based test could better predict treatment outcomes for prostate cancer patients

CMS to cover low-dose CT screening for lung cancer

Breakthrough study shows novel molecular imaging drug to detect early prostate cancer

New treatment could halt growth of tumours in prostate cancer patients

Inovio Pharmaceuticals reports Q3 2014 financial results, provides corporate update

Researchers obtain detailed picture of how Gas5 RNA interacts with steroid hormone receptors

Integrative medicine therapies can decrease pain, anxiety for hospitalized cancer patients

Olaparib shows promise for advanced cancers associated with BRCA1 and BRCA2 mutations

Researchers develop diagnostic tool to examine traveling cancer cells, improve health outcomes

AZD3965 drug inhibits growth of tumours in the lab

ProstaCaid dietary supplement supports prostate health

UT Arlington professor uses tissue-engineered artificial lymph nodes to draw prostate cancer cells

New device facilitates diagnosis of prostate cancer

Bluebeards Original joins with Lung Cancer Alliance to raise awareness about lung cancer

Study suggests possible link between body fat and risk of immunotherapy toxicity

UC Davis researchers link increased body fat and lethal drug reactions in mice

Findings could lead to single blood test for early detection of many types of cancer

What to know about prostate cancer eBook

Unlocking live single-cell functional insights

Fluidics in Modern Healthcare & Medical Device Innovation

How microRNA is transforming science: From discovery to diagnostics

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

What to know about prostate cancer eBook

Unlocking live single-cell functional insights

Fluidics in Modern Healthcare & Medical Device Innovation

How microRNA is transforming science: From discovery to diagnostics

Newsletters you may be interested in